Since it was shown that reverting EMT could restore sensitivity of lung cancer cells to targeted therapy20, we examined the effect of ZEB1 siRNA on the response of CD18-JQ1R cells to JQ1. This evidence concerns the gene ITGB2 and lung carcinoma.